129 related articles for article (PubMed ID: 12488647)
1. Pravastatin promotes coronary collateral circulation in patients with coronary artery disease.
Nishikawa H; Miura S; Zhang B; Shimomura H; Arai H; Tsuchiya Y; Saku K
Coron Artery Dis; 2002 Nov; 13(7):377-81. PubMed ID: 12488647
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibitor promotes coronary collateral circulation in patients with coronary artery disease.
Miura S; Nishikawa H; Zhang B; Matsuo Y; Kawamura A; Tsuchiya Y; Matsuo K; Saku K
Circ J; 2003 Jun; 67(6):535-8. PubMed ID: 12808273
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II type 1 receptor blockers do not promote coronary collateral circulation in patients with coronary artery disease.
Imaizumi S; Miura S; Nishikawa H; Iwata A; Zhang B; Kawamura A; Tsuchiya Y; Kumagai K; Matsuo K; Saku K
Hypertens Res; 2006 Mar; 29(3):135-41. PubMed ID: 16755148
[TBL] [Abstract][Full Text] [Related]
4. Effect of mild endurance exercise training and pravastatin on peripheral vasodilatation of forearm resistance vessels in patients with coronary artery disease.
Allemann Y; Vetter C; Kartal N; Eyer S; Stengel SM; Saner H; Hess OM
Eur J Cardiovasc Prev Rehabil; 2005 Aug; 12(4):332-40. PubMed ID: 16079640
[TBL] [Abstract][Full Text] [Related]
5. Effect of statin treatment on coronary collateral development in patients with diabetes mellitus.
Dincer I; Ongun A; Turhan S; Ozdol C; Ertas F; Erol C
Am J Cardiol; 2006 Mar; 97(6):772-4. PubMed ID: 16516573
[TBL] [Abstract][Full Text] [Related]
6. Functional evaluation of lipid-lowering therapy by pravastatin.
Schoebel FC; Jax TW; Strauer BE; Leschke M
Circulation; 1998 May; 97(18):1874-5. PubMed ID: 9603548
[No Abstract] [Full Text] [Related]
7. Cholesterol reduction improves myocardial perfusion abnormalities in patients with coronary artery disease and average cholesterol levels.
Mostaza JM; Gomez MV; Gallardo F; Salazar ML; Martín-Jadraque R; Plaza-Celemín L; Gonzalez-Maqueda I; Martín-Jadraque L
J Am Coll Cardiol; 2000 Jan; 35(1):76-82. PubMed ID: 10636263
[TBL] [Abstract][Full Text] [Related]
8. Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE).
Deedwania P; Stone PH; Bairey Merz CN; Cosin-Aguilar J; Koylan N; Luo D; Ouyang P; Piotrowicz R; Schenck-Gustafsson K; Sellier P; Stein JH; Thompson PL; Tzivoni D
Circulation; 2007 Feb; 115(6):700-7. PubMed ID: 17283260
[TBL] [Abstract][Full Text] [Related]
9. Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: coronary artery disease regression single photon emission computed tomography monitoring trial.
Schwartz RG; Pearson TA; Kalaria VG; Mackin ML; Williford DJ; Awasthi A; Shah A; Rains A; Guido JJ
J Am Coll Cardiol; 2003 Aug; 42(4):600-10. PubMed ID: 12932588
[TBL] [Abstract][Full Text] [Related]
10. B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS).
de Groot E; Jukema JW; Montauban van Swijndregt AD; Zwinderman AH; Ackerstaff RG; van der Steen AF; Bom N; Lie KI; Bruschke AV
J Am Coll Cardiol; 1998 Jun; 31(7):1561-7. PubMed ID: 9626835
[TBL] [Abstract][Full Text] [Related]
11. Association between the dosage and duration of statin treatment with coronary collateral development.
Dincer I; Ongun A; Turhan S; Ozdol C; Kumbasar D; Erol C
Coron Artery Dis; 2006 Sep; 17(6):561-5. PubMed ID: 16905969
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol lowering with pravastatin improves resistance artery endothelial function: report of six subjects with normal coronary arteriograms.
Houghton JL; Pearson TA; Reed RG; Torosoff MT; Henches NL; Kuhner PA; Philbin EF
Chest; 2000 Sep; 118(3):756-60. PubMed ID: 10988199
[TBL] [Abstract][Full Text] [Related]
13. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
Hague W; Forder P; Simes J; Hunt D; Tonkin A;
Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
[TBL] [Abstract][Full Text] [Related]
14. Design, rational, and baseline characteristics of the Prospective Pravastatin Pooling (PPP) project--a combined analysis of three large-scale randomized trials: Long-term Intervention with Pravastatin in Ischemic Disease (LIPID), Cholesterol and Recurrent Events (CARE), and West of Scotland Coronary Prevention Study (WOSCOPS).
Am J Cardiol; 1995 Nov; 76(12):899-905. PubMed ID: 7484829
[TBL] [Abstract][Full Text] [Related]
15. Statin use is associated with enhanced collateralization of severely diseased coronary arteries.
Pourati I; Kimmelstiel C; Rand W; Karas RH
Am Heart J; 2003 Nov; 146(5):876-81. PubMed ID: 14597938
[TBL] [Abstract][Full Text] [Related]
16. Low-density lipoprotein size, pravastatin treatment, and coronary events.
Campos H; Moye LA; Glasser SP; Stampfer MJ; Sacks FM
JAMA; 2001 Sep; 286(12):1468-74. PubMed ID: 11572739
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study).
Arntz HR; Agrawal R; Wunderlich W; Schnitzer L; Stern R; Fischer F; Schultheiss HP
Am J Cardiol; 2000 Dec; 86(12):1293-8. PubMed ID: 11113401
[TBL] [Abstract][Full Text] [Related]
18. Pravastatin and coronary heart disease.
Meyer FP
N Engl J Med; 1999 Apr; 340(14):1115-6; author reply 1116-7. PubMed ID: 10206830
[No Abstract] [Full Text] [Related]
19. Bradycardia is associated with development of coronary collateral vessels in humans.
Patel SR; Breall JA; Diver DJ; Gersh BJ; Levy AP
Coron Artery Dis; 2000 Sep; 11(6):467-72. PubMed ID: 10966132
[TBL] [Abstract][Full Text] [Related]
20. [Value of evaluating the coronary collateral circulation by transluminal attenuation gradient in patients with chronic total occlusion and related influencing factors].
Chen YL; Wang R; He Y; Li JN; Yuan F; Tian R; Ge CJ; Zhou Y; Huang RC; Cui S; Song XT
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Oct; 45(10):857-861. PubMed ID: 29081175
[No Abstract] [Full Text] [Related]
[Next] [New Search]
